Literature DB >> 819582

Analysis of complement-dependent antibody-mediated lysis of target cells acutely infected with measles.

J T Hicks, M J Klutch, P Albrecht, M M Frank.   

Abstract

A sensitive assay for the detection of complement-dependent cytolytic measles-antibodies in monkey and human sera is described. The high sensitivity of the technique is dependent upon the use of Vero or MA-104 cells acutely infected with a high-titered, non-syncitiogenic strain of attenuated measles virus. Cytolytic antibody titers of serum can be determined either by endpoint dilution in the presence of a standard dilution of heterologous (guinea pig) complement or by percentage of lysis of a specific number of target cells at a standard dilution of immune serum (1:32). The latter technique proved expedient in the comparison of cytolytic activities of large numbers of serum samples. Clearly, the alternative complement pathway is effective in lysis of these cells, but neither the classical nor the alternative pathway alone appears to be as effective as both pathways combined. No prozone effect occurred with homologous complement, and inhibition of lysis was eliminated by washing sensitized cells before addition of heterologous complement. Lysis of measles-infected cells untreated with measles antibody occurred in the presence of both normal and C4-deficient guinea pig serum at high concentrations, but no such activity occurred with non-immune human or rhesus serum. Antibody-mediated complement-dependent lysis of measles-infected cells may be an important immune defense against acute measles infection.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 819582

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Comparison of complement dependent lytic, hemagglutination inhibition and microneutralization antibody responses in influenza vaccinated individuals.

Authors:  Mary Dawn T Co; John Cruz; Akira Takeda; Francis A Ennis; Masanori Terajima
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

2.  Antibody enhances killing of Tritrichomonas foetus by the alternative bovine complement pathway.

Authors:  M K Aydintug; R W Leid; P R Widders
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

3.  Relationship of preexisting influenza hemagglutination inhibition, complement-dependent lytic, and antibody-dependent cellular cytotoxicity antibodies to the development of clinical illness in a prospective study of A(H1N1)pdm09 Influenza in children.

Authors:  Mary Dawn T Co; Masanori Terajima; Stephen J Thomas; Richard G Jarman; Kamonthip Rungrojcharoenkit; Stefan Fernandez; In-Kyu Yoon; Darunee Buddhari; John Cruz; Francis A Ennis
Journal:  Viral Immunol       Date:  2014-08-20       Impact factor: 2.257

4.  Antibody-independent activation of the alternative complement pathway by measles virus-infected cells.

Authors:  J G Sissons; M B Oldstone; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

5.  Antibody-dependent cytotoxicity against Trypanosoma rhodesiense mediated through an alternative complement pathway.

Authors:  B Flemmings; C Diggs
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

6.  Hemagglutinin-specific complement-dependent cytolytic antibody response to influenza infection.

Authors:  M W Verbonitz; F A Ennis; J T Hicks; P Albrecht
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

7.  Lysis of measles virus-infected cells by the purified cytolytic alternative complement pathway and antibody.

Authors:  J G Patrick Sissons; R D Schreiber; L H Perrin; N R Cooper; H J Müller-Eberhard; M B Oldstone
Journal:  J Exp Med       Date:  1979-09-19       Impact factor: 14.307

Review 8.  Antibody-mediated destruction of virus-infected cells.

Authors:  J G Sissons; M B Oldstone
Journal:  Adv Immunol       Date:  1980       Impact factor: 3.543

Review 9.  Complement, viruses, and virus-infected cells.

Authors:  N R Cooper; G R Nemerow
Journal:  Springer Semin Immunopathol       Date:  1983
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.